A first-in-human phase 1 study of LY3410738, a covalent inhibitor of mutant IDH, in advanced myeloid malignancies
Courtney D. DiNardo, Pau Montesinos,Lina Benajiba,Ana Triguero, Christian Recher,Andre C. Schuh,Mael Heiblig,Ashish Bajel,Arnaud Pigneux, Juan M. Alonso-Domiguez,Amir T. Fathi,Carolyn Grove,Hsin-An Hou,Michael Heuser,Sarit Assouline,Shaun Fleming, Dong-Yeop Shin,Kendra Sweet,Olatoyosi Odenike,Jessica Altman,Melissa Gaik Ming Ooi,Lao Zhentang, Nobert Vey,Joshua Zeidner,Amandeep Salhotra,Eunice Wang,Gary Schiller,Kimmo Porkka,Tsila Zuckerman,Violaine Havelange,Brian A. Jonas, Sujaatha Narayanan,Jun Ho Jang,Je-Hwan Lee,Anna M. Szpurka, Dana Heirich,Hsiao Rong Chen, Violet Hanft, Junjie Zhao, Ivelina Gueorguieva,Yin Zhang,Eytan M. Stein CANCER RESEARCH(2023)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)